This breakthrough has accelerated peptide drug development across multiple therapeutic areas, including cardiovascular ...
In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at ...
NYSE-listed Alto Neuroscience has raised $120 million in a private placement that will be used to advance its recently acquired candidate for treatment-resistant depression (TRD) into a pivotal trials ...
A patient advocacy group in the UK is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent that has killed two young people and left nearly a dozen others ...